Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, pilot study. A total of 30 subjects (15 in each study
arm) will be enrolled in this 6 month study to evaluate whether the addition of narrow band
UVB (NB-UVB) phototherapy can enhance the efficacy of etanercept's maintenance dose, 50 mg
once a week, in obese psoriasis patients.